101.
The thrifty phenotype hypothesis revisited
by Vaag, A. A
Diabetologia, 2012-05-30, Vol.55 (8), p.2085-2088
102.
Translational insights from single-cell technologies across the cardiovascular disease continuum
by van Blokland, Irene V
Trends in cardiovascular medicine, 2022-04, Vol.32 (3), p.127-135
103.
Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women
by Sarnowski, Chloé
Menopause (New York, N.Y.), 2018-04, Vol.25 (4), p.451-457
104.
Association of cytochrome P450 2C192 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents
by Oh, Il-Young
Heart (British Cardiac Society), 2012-01, Vol.98 (2), p.139-144
105.
Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes
by Feodoroff, Maija
Diabetologia, 2018-09-18, Vol.61 (12), p.2580-2589
106.
Long noncoding RNA variations in cardiometabolic diseases
by Dechamethakun, Sariya
Journal of human genetics, 2017-01, Vol.62 (1), p.97-104
107.
Atrial Natriuretic Peptide Genetic Variant rs5065 and Risk for Cardiovascular Disease in the General Community: A 9-Year Follow-Up Study
by Cannone, Valentina
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.860-865
108.
RNA-stabilizing proteins as molecular targets in cardiovascular pathologies
by Suresh Babu, Sahana, MRes, PhD
Trends in cardiovascular medicine, 2015, Vol.25 (8), p.676-683
109.
Family history in public health practice: a genomic tool for disease prevention and health promotion
by Valdez, Rodolfo
Annual review of public health, 2010, Vol.31 (1), p.69-87
110.
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
by Pirillo, Angela
Cardiology, 2013-03, Vol.124 (2), p.116-125
111.
Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models
by Patti, Mary-Elizabeth
Cellular and molecular life sciences : CMLS, 2013-02-23, Vol.70 (9), p.1597-1608
112.
Current Status of Messenger RNA Delivery Systems
by Matthew G Stanton
Oligonucleotides, 2018-06-01, Vol.28 (3), p.158
113.
Modeling Cardiovascular Disease in the Zebrafish
by Chico, Timothy J.A
Trends in cardiovascular medicine, 2008, Vol.18 (4), p.150-155
114.
Genetic Predisposition to Higher Blood Pressure Increases Risk of Incident Hypertension and Cardiovascular Diseases in Chinese
by Lu, Xiangfeng
Hypertension (Dallas, Tex. 1979), 2015-10, Vol.66 (4), p.786-792
115.
Mapping eQTLs in the Norfolk Island Genetic Isolate Identifies Candidate Genes for CVD Risk Traits
by Benton, Miles C
American journal of human genetics, 2013-12-05, Vol.93 (6), p.1087-1099
116.
The clinical characteristics of Asian patients with classical-type Hutchinson-Gilford progeria syndrome
by Sato-Kawano, Nanae
Journal of human genetics, 2017-12, Vol.62 (12), p.1031-1035
117.
Two-Variance-Component Model Improves Genetic Prediction in Family Datasets
by Tucker, George
American journal of human genetics, 2015-11-05, Vol.97 (5), p.677-690
118.
Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis
by Elghoroury, Eman A
Pediatric nephrology (Berlin, West), 2018-01-08, Vol.33 (6), p.1019-1027
119.
Biological ageing and cardiovascular disease
by Samani, Nilesh J
Heart (British Cardiac Society), 2008-05, Vol.94 (5), p.537-539
